Work

Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: AIDS

DOI: 10.1097/01.aids.0000183633.06580.8a

Authors: Jacob Lalezari, Melanie Thompson, Priny Kumar, Peter Piliero, Richard Davey, Kristine Patterson, Anne Shachoy-Clark, Kimberly Adkison, James Demarest, Yu Lou, Michelle Berrey, Stephen Piscitelli

Institutions: Quest Clinical Research (United States), AIDS Research Consortium of Atlanta, Georgetown University, Albany Medical College, National Institutes of Health, National Institute of Allergy and Infectious Diseases, University of North Carolina at Chapel Hill

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2050977299

FWCI: 10.63

Cites: 8

Cited by: 111

Related to: 10